# Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study

> **NCT06528431** · PHASE4 · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 180 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Clinical tapering strategy
- **DRUG:** Step Wedge trial

## Key facts

- **NCT ID:** NCT06528431
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-19
- **Primary completion:** 2026-09-19
- **Final completion:** 2027-12-19
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528431, "Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06528431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*